Navigation Links
Mesenchymal Stem Cells Market- MSC Product is Stem Cells Fastest Growing Area Says New Research Report at

Dallas, Texas (PRWEB) May 12, 2013

Analysis of global grant activity, scientific publication rates, and patent applications reveal that research activity involving mesenchymal stem cells increased 58% year-over-year from 2008 to 2009, and 112% from 2009 to 2010. Of most interest is that this rate of growth accelerated in 2011, making mesenchymal stem cells the fastest growing area of stem cell research.

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases.

Revealing Unique Strategic Opportunities & Unknown Competitive Advantages
MSCs are advantageous over other stem cells types for several reasons. First, they avoid the ethical issues that surround embryonic stem cell research. Second, repeated studies have found that human MSCs are immuno-privileged, and therefore, represent an advantageous cell type for allogenic transplantation, reducing the risks of rejection and complications of transplantation. Recently, there have also been significant advances in the use of autologous MSCs to regenerate human tissues, including cartilage and meniscus, tendons, and bone fractures.

This market research report focuses on recent advances in Mesenchymal stem cells research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. The report advantageously positions companies that wish to offer competitive stem cells products to this rapidly growing, well-funded research community.

Expanded and Updated Market Intelligence
This is an expanded and updated market intelligence report that includes:

  •     Updated Charts, Timelines, Metrics and Financials
  •     5-Year Projection Data through 2016
  •     Expanded Competitive Environment Analysis
  •     Detailed Characterization of the Market, Emphasizing Statistical Trends
  •     Exploration of Recent Product Evolution and Projected Directions for Development
  •     Overview of Therapeutic Progress and Insight into Future Applications
  •     Detailed Evaluation of Profit Opportunities
  •     New Section on End-User Needs & Technical Preferences (Scientist Survey!)

Highlights of this report “” include:

  •     Charts, Timelines, Metrics and Financials
  •     Rates of MSC Grants, Publications, and Patents
  •     Market Characterization and 5-Year Projections
  •     Breakdown of MSC Research Activity by Application, Species, Tissue Source
  •     Geographical Assessment of Market Demand
  •     Competitive Environment Analysis, by MSC Product Supplier
  •     Recent Product Evolution and Unmet Market Needs
  •     Online Advertising Assessment and Opportunities for Targeted Traffic
  •     Revealing Survey of ones Prospective Clients - MSC Scientists
  •     End-User Wants, Technical Preferences, Factors Influencing Buying Decisions
  •     And Much More.
The market intelligence contained in this report was compiled using a broad range of sources, including:
  •     MSC grant funding (NIH database, DoD database)
  •     MSC patents (USPTO)
  •     MSC publications (PubMed, Highwire Press)
  •     MSC product launch announcements (Google News, Trade Journals)
  •     International surveys (electronically distributed end-user surveys)
  •     And more

These sources were used to identify recent advances in MSC research applications, explore research priorities by market segment, highlight individual labs and end-users of MSC research products, explore the competitive environment for MSC research products, and provide 5-year growth and trend analysis. As such, this market intelligence report will advantageously position one’s company to offer competitive MSC products to this rapidly growing, well-funded research community.

Can also access information on:

  •     Recent Product Evolution
  •     Projected Directions for Development
  •     Overview of Therapeutic Progress and Insight into Future Applications
  •     Detailed Evaluation of Profit Opportunities for Research Product Suppliers

In summary, literature and data concerning the biology and differentiation potential of mesenchymal stem cells (MSCs) has become huge in less than 10 years, now totaling nearly 13,000 publications, although some data does present as contradictory, suggesting a heterogenic nature for MSC populations depending on source tissue, species, and donor characteristics. MSCs appear to be an exceptionally promising tool for cell therapy because of their unusual characteristics, which partially mimic those of embryonic stem cells, but have advantages in terms of availability, expandability, transplantability, and ethical implications.

Interest in therapeutic applications of human MSCs arises from their diverse ability to differentiate into a range of cell types, as well as from their ability to migrate to sites of tissue injury/inflammation or tumor growth. These localization properties present a promising strategy for targeted introduction of therapeutic agents through MSC gene therapy. In addition, MSCs possess strong immunosuppressive properties that medical researchers are exploiting for both autologous as well as heterologous therapies.

Buy a copy of report @

Explore on reports on Biotechnology Market and Stem Cell Market.

About Us ( is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Stemedica and Scripps to Jointly Investigate Therapeutic Effect of Ischemia Tolerant Mesenchymal Stem Cells (itMSC) and Stem Cell Factors in Lung Injury and Sepsis
2. Study reveals insights that could aid in therapeutic use of mesenchymal stem cells
3. Protect Cell Viability Outside the Incubator While Trypsinizing Cells During Cell Passaging with the Scienceware® CultureTemp™ 37°C Warming Plate by Bel-Art Products
4. Duke researchers describe how breast cancer cells acquire drug resistance
5. UCLA study shows that individual brain cells track where we are and how we move
6. Temple scientists weaken HIV infection in immune cells using synthetic agents
7. Mast cells give clues in diagnosis, treatment of dengue
8. Battery of tests on cancer cells shows them as squishy, yet tactically strong
9. New research findings on the brains guardian cells
10. Virus kills melanoma in animal model, spares normal cells
11. Screening detects ovarian cancer using neighboring cells
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... It’s inevitable that everyone ... member, close friend, or animal pass away, death lives among us. It is your ... Coming from a family of 11 children, author T Sky understands that she may ...
(Date:11/30/2015)... ... November 30, 2015 , ... Sikka Software announced today that they are showcasing ... dentists to make complex business decisions by providing the tools and information they need ... survey with 10 procedures customized by zip code. , The Sikka Software Ecosystem ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue repair in the US ... is a long-term resorbable surgical mesh intended to support and reinforce soft tissue ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... be of critical importance to the medical schools of the future. To reach ... healthcare suite at the 2015 ChangeMedEd conference in Chicago, organized by the American ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... a leading provider of enterprise Time and Attendance/Workforce Management cloud-based solutions, announced ... Microsoft Partner Program with competencies in the Application Development, demonstrating a “best-in-class” ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)...  Kevin Smith has been appointed Chief Commercial ... in wireless monitoring of vital signs.  As CCO ... Mr. Smith will be responsible for the development ... will also directly oversee partnering with US hospitals ... SensiumVitals, the first early warning detection device to ...
(Date:11/30/2015)... LAKE, N.J. and SAN DIEGO ... and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today ... has accepted for filing the New Drug Application (NDA) ... the extended release formulation will offer patients a chronic ... ® ) is currently approved as an ...
(Date:11/30/2015)... 30, 2015 iCAD, Inc. (Nasdaq: ... its latest solutions for advanced image analysis and ... at the Radiological Society of North American (RSNA) ... from November 29 to December 4, 2015. ... iReveal®, an automated breast density assessment solution, PowerLook® ...
Breaking Medicine Technology: